U.S. FDA staff review of NPS drug sparks stock rebound

[riky]

U.S. FDA staff review of NPS drug sparks stock rebound

<p><a href="http://news.yahoo.com/fda-staff-nps-drug-effective-no-significant-safety-132359577--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/VKBFDGD.3ei_XE7NeE4W5Q--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-09-10T132359Z_1_LYNXMPEA890LG_RTROPTP_2_CHINA-PHARMACEUTICALS.JPG" width="130" height="86" alt="A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring" align="left" title="A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring" border="0" /></a>By Toni Clarke WASHINGTON (Reuters) - Shares in NPS Pharmaceuticals Inc soared on Wednesday after a preliminary report from U.S. NPS shares rose 25 percent to close at $32.24. The report, posted on Wednesday on the FDA's website, came two days ahead of a meeting of outside advisers to the agency who will discuss the drug and recommend whether it should be approved. The FDA reviewer said serious adverse events were similar between the treatment group and the placebo group.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login